Back to search
NSCLC, Stage I, II, III
Clinical trial pipeline · Data from ClinicalTrials.gov
See which NSCLC, Stage I, II, III trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which NSCLC, Stage I, II, III trials you may qualify forBDTX-4933-101 is a first-in-human, open-label, Phase 1/2 dose escalation, dose optimization and expansion study designed to evaluate the safety and tolerability…
This trial studies how well dyadic yoga intervention works in improving physical performance and quality of life in patients with stage I-IV non-small cell lung…
This phase I/II trial tests the safety, side effects and best dose of sotorasib with trastuzumab deruxtecan and how well the combination works in treating patie…
This phase I/II trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients…
The goal of this clinical trial is to compare a new way of using magnetic resonance-guided adaptive radiation therapy (MRgART) to the standard of care linear ac…
This trial studies the role of the gut microbiome and effectiveness of a fecal transplant on medication-induced gastrointestinal (GI) complications in patients…
This phase III trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer.…
This study compares the outcomes and safety of two standard treatment options called microwave ablation and surgical wedge resection in patients with non-small…